Aveo oncology share price

1 Year % Chg -57.56. Market Cap 55.8M. Shares Outstanding 16.1M. Beta 0.85. Dividend (Yield) -. Div Amount -. Ex Div Date -. Earnings Date 2020-05-08. Split History. Stock splits are used by AVEO Pharmaceuticals, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of 

AVEO Oncology: Market Approves FOTIVDA's Updated OS HR ... Sep 13, 2019 · AVEO recently publicized the results of their interim analysis of FOTIVDA in advanced RCC. The company reported an improved OS HR ratio of 0.99.The market embraced the results and the share price rock Advanced Oncotherapy Share Price. AVO - Stock Quote ... Over the last year, Advanced Oncotherapy share price has been traded in a range of 31.5, hitting a high of 52, and a low of 20.5. Intraday Advanced Oncotherapy Share Chart. AVEO | AVEO Pharmaceuticals Inc. Profile | MarketWatch

AVEO Stock News - Fidelity

Jan 29, 2020 · AVEO Oncology Announces Appointment of Scarlett Spring to its Board of Directors Business Wire CAMBRIDGE, Mass. -- November 19, 2019 AVEO Oncology (NASDAQ: AVEO) today announced the appointment of AVEO Stock Price Quote & News - AVEO Pharmaceuticals ... View the real-time AVEO price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare AVEO Pharmaceuticals against related stocks people have also bought like VSTM, OCGN, INPX, and BIOC. 5,627 people own AVEO Pharmaceuticals on … AVEO Pharmaceuticals (NasdaqCM:AVEO) - Share price, News ... How has AVEO Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events. Stable Share Price: AVEO's share price has been volatile over the past 3 months develops and commercializes a portfolio of targeted medicines for oncology and other areas of unmet medical need. It markets its Aveo Pharmaceuticals, Inc. - AVEO - Stock Price Today - Zacks

AVEO Pharmaceuticals Price | AVEO

AVEO Pharmaceuticals Inc (NASDAQ:AVEO) Share Price and News. AVEO Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted medicines for oncology and other areas of unmet medical need. The Company’s strategy is to retain North American rights to its oncology portfolio while securing partners in development and … AVEO Pharmaceuticals Inc. Stock Price (AVEO) | Barron's Apr 03, 2020 · View today's stock price, news and analysis for AVEO Pharmaceuticals Inc. (AVEO). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation AVEO | Stock Snapshot - Fidelity Apr 03, 2020 · aveo pharmaceuticals inc (aveo): * aveo oncology reports full year 2019 financial results and provides business update. * aveo pharmaceuticals (aveo) - cash, cash equivalents and marketable securities of about $47.7 million at dec 31, 2019, would allow co to fund planned operations into q2 of 2021.

AVEO Pharmaceuticals Inc. is a biopharmaceutical company. It is engaged in discovering developing and commercializing novel cancer therapeutics.

View the real-time AVEO price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare AVEO Pharmaceuticals against related stocks people have also bought like VSTM, OCGN, INPX, and BIOC. 5,627 people own AVEO Pharmaceuticals on … AVEO Pharmaceuticals (NasdaqCM:AVEO) - Share price, News ... How has AVEO Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events. Stable Share Price: AVEO's share price has been volatile over the past 3 months develops and commercializes a portfolio of targeted medicines for oncology and other areas of unmet medical need. It markets its

Aveo Pharmaceuticals started at outperform with $3 stock price target at FBR & Co. MarketWatch. Thursday, January 08, 2015 AVEO Oncology Announces Submission of New Drug Application to U.S. FDA for Tivozanib in Patients with Relapsed or Refractory Renal Share, Size, Growth, Opportunity and Forecast 2020-2026 by Ameco Research Market

Aveo Pharmaceuticals started at outperform with $3 stock price target at FBR & Co. MarketWatch. Thursday, January 08, 2015 AVEO Oncology Announces Submission of New Drug Application to U.S. FDA for Tivozanib in Patients with Relapsed or Refractory Renal Share, Size, Growth, Opportunity and Forecast 2020-2026 by Ameco Research Market

Dec 30, 2014 · A Cambridge biotech struggling to claw its way back after a devastating FDA rejection in 2013, Aveo Oncology has been notified that its stock stock price is too low to remain on the Nasdaq Global Earnings Whisper Number for AVEO: Aveo Pharmaceuticals Aug 08, 2019 · Aveo Pharmaceuticals (AVEO) reports earnings on 6/15/2020. Shares are up 17.2% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. Aveo Pharmaceuticals Inc, AVEO:NAQ summary - FT.com Latest Aveo Pharmaceuticals Inc (AVEO:NAQ) share price with interactive charts, historical prices, comparative analysis, AVEO Oncology Announces Submission of New Drug Application to U.S. FDA for Tivozanib in Patients with Relapsed or Refractory Renal Cell Carcinoma Share price information may be rounded up/down and therefore not AVEO Pharmaceuticals Inc (NASDAQ:AVEO) Share Price | RNS ... AVEO Pharmaceuticals Inc (NASDAQ:AVEO) Share Price and News. AVEO Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted medicines for oncology and other areas of unmet medical need. The Company’s strategy is to retain North American rights to its oncology portfolio while securing partners in development and …